Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > ChiChi continues to make up BS

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jul 30, 2023 1:12pm

112 Views

Post# 35563798

RE:ChiChi continues to make up BS

I suppose the market is ignorant and you are very smart thus the share price is in the can at the lowest point in ten years only becasue of the good retained earning. Shake your head as there is nothing left in the pockets to shake

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project